Seeking Alpha

GlaxoSmithKline (GSK -0.8%) says it's planning to review its European operations in response to...

GlaxoSmithKline (GSK -0.8%) says it's planning to review its European operations in response to continued pressure on drug prices in Europe and lower overall demand for vaccines. Although it's unclear on what impact the review could have on staff numbers, consensus opinion is that the move signals downsizing.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs